Nobel Prize for malaria drug development

China's Youyou Tu was awarded half of the Nobel Prize for Medicine for discovering artemisinin, a drug that has been used to successfully reduced mortality from Malaria. It is estimated, when used in combination therapy for Malaria, that the use of artemisinin can reduce mortality by 20% overall and 30% in children. Read more here.

Global Health Group launches new website

The Global Health Group has launched its new website, shrinkingthemalariamap.org, which features an interactive map that highlights the global progress towards the goal of malaria elimination. The website aims to emphasize the resilient regional collaborations, offer information o­n the latest policy and financing, and provide a o­ne-stop-shop for malaria elimination resources.

Agenda for upcoming APMEN Vivax Working Group meeting

At the upcoming APMEN Vivax Working Group meeting a number of strategic documents will be reviewed, including: The WHO's Technical brief for control and elimination of P.vivax and the Malaria Global Technical Strategy for Malaria 2016-2030, the Strategy for Malaria Elimination in the Greater Mekong Subregion 2015-2030, and Roll Back Malaria?s Action and Investment to defeat Malaria  2016-2030. With over 16 million cases of P.vivax infection recorded in 2013, eradicating P.vivax remains a top priority for the group.

UPCOMING EVENTS

P.vivax publication:

The challenges of introducing routine G6PD testing into radical cure: a workshop report
         Primaquine has proven to be an effective drug to use against malaria infection; however Primaquine can induce rupture of red blood cells in individuals that are deficient in glucose-6-phosphate dehydrogenase (G6PD), an enzyme needed to maintain regular functioning of red blood cells. This paper discusses the challenges of testing for G6PD deficiency in patients before administering Primaquine, a procedure that is currently recommended by the WHO. Find the full article here.

Surveillance and Response Working Group Update

Since their last meeting in May, the APMEN Surveillance and Response Working Group (SRWG) has actioned two important projects from the 2015-2016 SRWG workplan:
1) Sharing the elimination and prevention of reintroduction (POR) indicators, with the Global Fund, Gates foundation, the WHO, and other key partners, and
2) Collecting and sharing of malaria program Standard Operating Procedures o­n the response component of surveillance and response, which includes strong examples shared with the network to inform country program efforts.

Read more about the group.

APMEN farewells Kylie

Since starting at APMEN in 2011, Kylie has played an integral role in the research grants and technical capacity building at the APMEN Vivax working team based at Menzies School of Health Research in Darwin and more recently in Cambodia. We wish her well as she moves o­n to join the APMEN Partner Institution, Malaria Consortium, where she will lead the coordination with the different partners involved in Cambodia and Thailand as the GF-RAI Regional Programme Manager.

Other news »

---

• The collaborative mission of IMPE-QN, WHO, and RAI investigates malaria situation in Khanh Hoa province (11/28/2023)
• IMPE-QN cooperated with Korea's leading universities in Bio-health research and training (11/20/2023)
• IMPE-QN welcomes international units to visit and exchange research cooperation (06/05/2023)
• MOU Signing Ceremony and Joint Scientific Seminar between the Institute of Malariology, Parasitology and Entomology and Gyeongsang National University (Republic of Korea) (12/09/2022)
• US Naval Medical Research Unit (NAMRU-2) visits to and exchanges research cooperation with IMPE-QN (08/16/2022)